102.00
+2.00
+(2.00%)
As of 8:00:27 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 9 | 8 |
| Avg. Estimate | 847.42M | 884.01M | 3.66B | 3.84B |
| Low Estimate | 806.6M | 860.2M | 3.5B | 3.64B |
| High Estimate | 870.81M | 918.65M | 3.75B | 4.08B |
| Year Ago Sales | 804M | 848M | 3.57B | 3.66B |
| Sales Growth (year/est) | 5.40% | 4.25% | 2.59% | 5.01% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| H9B1.F | -- | -- | -- | -- |
| S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Upgrades & Downgrades
| Maintains | JP Morgan: Neutral to Neutral | 4/14/2025 |
| Maintains | Citigroup: Buy to Buy | 4/8/2025 |
| Initiated | Citigroup: Buy | 3/24/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 3/19/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 12/12/2024 |
| Maintains | Goldman Sachs: Buy to Buy | 10/23/2024 |